Exenatide as a novel treatment for Parkinson's Disease
PD is a progressive neurodegenerative disease that results in intolerable disability for most patients despite the best current medical and surgical therapies. A treatment that slows, or stops clinical progression is the major therapeutic goal of current PD research. Multiple avenues of research inc...
Main Author: | Aviles-Olmos, I. |
---|---|
Other Authors: | Foltynie, T. ; Limousin, P. |
Published: |
University College London (University of London)
2013
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626452 |
Similar Items
-
The genetic basis and pathogenesis of Parkinson's disease and complex parkinsonisms
by: Kara, E.
Published: (2014) -
Olfaction in Parkinson's Disease
by: Silveira Moriyama, L.
Published: (2009) -
Functional networks in Parkinson's Disease
by: Jha, A.
Published: (2013) -
Glucocerebrosidase mutations and Parkinson's disease
by: McNeill, A.
Published: (2013) -
The cognitive heterogeneity of Parkinson's disease
by: Williams-Gray, Caroline Helen
Published: (2008)